Skip to main content
Livermore
Livermore
US stocksTW
ZHEN

Bicara Therapeutics Inc.

BCAX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002023658

In the last 90 days, Bicara Therapeutics Inc. insiders filed 0 open-market purchases and 1 sale; 172 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.

SEC filings

10-K, 10-Q, 8-K, 20-F and 40-F reports Bicara Therapeutics Inc. filed with the SEC, newest first.

Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.

SEC filings by Bicara Therapeutics Inc.
FiledForm8-K itemsPeriodDocumentFiling index
Nov 9, 202610-Q–Sep 30, 2026SECIndex
Nov 9, 20268-K2.029.01Nov 9, 2026SECIndex
Aug 25, 20268-K1.019.01Aug 21, 2026SECIndex
Aug 11, 202610-Q–Jun 30, 2026SECIndex
Aug 11, 20268-K2.029.01Aug 11, 2026SECIndex
Jul 28, 20268-K5.027.019.01Jul 23, 2026SECIndex
Jun 10, 20268-K5.07Jun 9, 2026SECIndex
May 21, 20268-K8.019.01May 21, 2026SECIndex
May 11, 202610-Q–Mar 31, 2026SECIndex
May 11, 20268-K2.029.01May 11, 2026SECIndex
Mar 30, 202610-K–Dec 31, 2025SECIndex
Mar 30, 20268-K2.029.01Mar 30, 2026SECIndex
Feb 26, 20268-K1.012.029.01Feb 24, 2026SECIndex
Feb 19, 20268-K8.019.01Feb 19, 2026SECIndex
Jan 12, 20268-K8.019.01Jan 12, 2026SECIndex
Dec 8, 20258-K7.018.019.01Dec 6, 2025SECIndex
Nov 10, 202510-Q–Sep 30, 2025SECIndex
Nov 10, 20258-K2.029.01Nov 10, 2025SECIndex
Aug 12, 202510-Q–Jun 30, 2025SECIndex
Aug 12, 20258-K2.029.01Aug 12, 2025SECIndex
Jun 12, 20258-K5.07Jun 9, 2025SECIndex
Jun 6, 20258-K1.019.01Jun 2, 2025SECIndex
May 13, 202510-Q–Mar 31, 2025SECIndex
May 13, 20258-K2.029.01May 13, 2025SECIndex
Mar 27, 202510-K–Dec 31, 2024SECIndex
Mar 27, 20258-K2.029.01Mar 27, 2025SECIndex
Jan 13, 20258-K7.019.01Jan 13, 2025SECIndex
Nov 12, 202410-Q–Sep 30, 2024SECIndex
Nov 12, 20248-K2.027.019.01Nov 12, 2024SECIndex
Sep 16, 20248-K5.039.01Sep 12, 2024SECIndex